Krill oil
Also called: Antarctic krill oil, Euphausia superba oil
An oil extracted from Antarctic krill (Euphausia superba), small shrimp-like marine crustaceans. It supplies the long-chain omega-3 fatty acids EPA and DHA, mainly in the form of phospholipids. General omega-3 information is in the omega-3 fatty acids entry.
- Category
- Fatty acid
- Forms
- Krill oil (omega-3s mainly as phospholipids); lysophosphatidylcholine-rich oil extracts of Antarctic krill also appear on FDA's NDI list
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-30
Class 1 Well studied in people. A 2023 systematic review and meta-analysis of randomized controlled trials included 14 trials (18 treatment arms, 1,458 participants) of krill oil supplementation and cardiovascular risk factors. [2]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BHeart and blood vessels1 topic
CBones and joints1 topic
XSeveral areas, whole body or blood1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Blood lipids | B | A 2017 meta-analysis (7 RCTs, 662 participants) found lower LDL cholesterol (-15.52 mg/dL) and triglycerides (-14.03 mg/dL) and higher HDL (+6.65 mg/dL); the change in total cholesterol was not significant. [3] |
| Blood pressure, glycemic control, body composition and inflammatory markers | X | A 2023 meta-analysis (14 trials, 1,458 participants) found lower total cholesterol, LDL and triglycerides but no effect on blood pressure, glycemic control, body composition or inflammatory markers. [2] |
| Knee pain, stiffness and function | C | A 2024 meta-analysis (5 RCTs, 700 patients) found no significant difference from placebo for knee pain, stiffness or lipids, and a small improvement in knee physical function (SMD -0.24). [4] |
Main constituents: Long-chain omega-3s (EPA and DHA), present primarily as phospholipids [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- The 2017 meta-analysis included trials of at least 2 weeks of krill oil supplementation. [3]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Score EABCDEA: well known causeE: unlikely cause
NIH LiverTox, Omega-3 Fatty Acids (last update April 8, 2017; the chapter names krill oil among marine sources): likelihood score E, unlikely cause …
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicines1 listed
Anticoagulants and antiplatelet agents
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications4 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- LiverTox (omega-3 fatty acids chapter, which names krill oil among marine oil sources): side effects of omega-3 supplements at typical doses are minimal (mild gastrointestinal discomfort, nausea, diarrhea, headache); platelet dysfunction and an increased risk of bleeding are more clinically significant. [5]
Interactions
| With | What happens |
|---|---|
| Anticoagulants and antiplatelet agents | LiverTox (omega-3 fatty acids): severe events with prescription omega-3 products may include an increased risk of bleeding, particularly with other anticoagulants or antiplatelet agents. [5] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- ODS: some studies suggest the phospholipid omega-3s in krill oil have somewhat higher bioavailability than the omega-3s in fish oil, whereas other studies do not. [1]
Regulatory status
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-30). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Omega-3s in the form of phospholipids Fatty acids and lipids (omega-3 phospholipids) [P6]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 4 entries naming krill oil or an oil extract of Antarctic krill (Euphausia superba) (earliest NDI 155 submitted 2002-03-13; most recent NDI 1360 submitted 2024-09-12); 4 more entries name other krill products (a protein concentrate, freeze-dried krill, krill powder and a krill enzyme product). Each notification covers one firm's specific ingredient and conditions of use; the list does not state FDA's response. [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- NIH LiverTox, Omega-3 Fatty Acids (last update April 8, 2017; the chapter names krill oil among marine sources): likelihood score E, unlikely cause of clinically apparent liver injury. [P7]
Interactions with medicines
- Anticoagulants and antiplatelet agents: LiverTox (omega-3 fatty acids): severe events with prescription omega-3 products may include an increased risk of bleeding, particularly with other anticoagulants or antiplatelet agents. [P7]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]
Supply and conservation
- IUCN Red List: Least Concern (LC) for Euphausia superba, via GBIF species API, retrieved 2026-10-30. [P8]
Absorption in people
- ODS: krill oil contains omega-3s primarily as phospholipids; some studies suggest somewhat higher bioavailability than the omega-3s in fish oil, whereas other studies do not. [P5]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (last update 2026-07-23; checked 2026-10-30), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606; checked 2026-10-30), 2026-10-30. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (current text, retrieved 2026-10-30), 2026-10-30. ecfr.gov
- NIH Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-24 per page metadata), 2026-10-24. ods.od.nih.gov
- NCCIH. Omega-3 Supplements: What You Need To Know (Last Updated: November 2024), 2024-11. nccih.nih.gov
- NIH LiverTox. Omega-3 Fatty Acids (Last Update: April 8, 2017), 2017-04-08. ncbi.nlm.nih.gov
- GBIF species API: IUCN Red List category for Euphausia superba Dana, 1850 (usageKey 2228010), 2026-10-30. api.gbif.org
Sources
- NIH Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-24 per page metadata), 2026-10-24. ods.od.nih.gov
- Huang H, et al. Clinical effectiveness of krill oil supplementation on cardiovascular health in humans: an updated systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr 2023;17(12):102909 (PMID 38039646), 2023-12. pubmed.ncbi.nlm.nih.gov
- Ursoniu S, et al. Lipid-modifying effects of krill oil in humans: systematic review and meta-analysis of randomized controlled trials. Nutr Rev 2017;75(5):361-373 (PMID 28371906), 2017-05-01. pubmed.ncbi.nlm.nih.gov
- Pimentel T, et al. Krill oil supplementation for knee pain: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials. Inflammopharmacology 2024;32(5):3109-3118 (PMID 39126570), 2024-10. pubmed.ncbi.nlm.nih.gov
- NIH LiverTox. Omega-3 Fatty Acids (Last Update: April 8, 2017), 2017-04-08. ncbi.nlm.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in fatty acid: Algal oil (DHA and EPA) · Arachidonic acid · Argan oil · Conjugated linoleic acid (CLA) · Evening primrose oil · GLA oils (borage and blackcurrant seed oil) · Linoleic acid · MCT oil (medium-chain triglycerides) · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.